'MyLab 30CV' Searchterm 'MyLab 30CV' found in 3 articles 3 booleans [ • ]Result Pages : • ![]() 'The MyLab™30CV ultrasound system is an evolutionary step in ultrasound technology. Weighing less than 20 pounds, it is the first compact ultrasound system to deliver premium console performance. And with mobile, portable or stationary configurations, MyLab30CV can adapt to any clinical environment.'
Device Information and Specification
APPLICATIONS
Abdominal, breast, cardiac, OB/GYN, pediatric, pediatric cardiology, small parts, transcranial, vascular
CONFIGURATION
Portable
Linear: 4-10 MHz, convex: 2-5 MHz, phased: 1.6-10 MHz, micro convex: 5-7.5 MHz, endocavity: 5-7.5 MHz, pencil: 2 + 5 MHz
2-D, M-mode, duplex, triplex, color Doppler, pulsed wave Doppler, tissue velocity mapping (TVM), tissue enhancement imaging (TEI™), contrast harmonic imaging, stress echo, tissue velocity mapping for LV motion analysis (TVM), contrast tuned imaging for contrast media procedures (CnTI™), Qontrast™ for myocardium parameters quantification
STORAGE, CONNECTIVITY, OS
Digital patient archive/management, integrated CD/RW, RJ 45 and USB ports, Windows
H*W*D m (inch.)
0.16 * 0.36 * 0.50 (6.2 x 14 x 19.3)
WEIGHT
Less than 11 kg (20 lbs.)
• ![]() 'BIOSOUND ESAOTE is an ISO9001/EN46001 certified major medical corporation operating as part of the international Esaote Group. With its parent company, Esaote, S.p.A. based in Genoa, Italy, ISO-9000 certified research and development and manufacturing facilities in Florence and Genoa, and North American headquarters in Indianapolis, the Esaote Group develops diagnostic ultrasound and magnetic resonance imaging (MRI) equipment for the worldwide medical community.' Ultrasound Related Product Lines: Ultrasound Systems:
•
•
•
•
•
• ![]() In 1988 Ote-Biomedica Elettronica S.p.A. and the biomedical division of Esacontrol S.p.A. were consolidated into a single company, Esaote Biomedica S.p.A., operating as a division of IRI-Finmeccanica. In 1987 the company began marketing its products in the United States through Biosound Inc., which it subsequently acquired in 1990. In the 1990's, the company began to strengthen its presence in Europe, establishing Esaote Biomedica France Sarl and Esaote Biomedica Deutschland GmbH. In July 1994 business activities and assets of Esaote Biomedica S.p.A. were transferred to the new company Esaote S.p.A. 1995-1998 the Bracco Group becoming the main Esaote shareholder with 50% of the share capital. In February 1997, Esaote established Esaote China Ltd. located in Hong Kong, and in April 1998 acquired Pie Medical Group, based in Maastricht - The Netherlands, which primarily operates in medical diagnostic ultrasound. Esaote-Pie Medical, is exclusively dedicated to the development and marketing of veterinary diagnostic ultrasound equipment. GE Healthcare is the exclusive U.S. distributor of devices manufactured by Esaote Biomedica. 'The Esaote Group is a global leader in research, production and marketing of medical diagnostic equipment and related services focused on solving the medical needs of our customers worldwide. With over 16% of its employees actively engaged in Research & Development, Esaote is pursuing new diagnostic technologies to be introduced in international healthcare markets.' Ultrasound Related Product Lines: For products dedicated to the veterinarian practice see Esaotes Pie Medical Equipment B.V. For products distributed in the United States see Biosound Esaote, Inc. Ultrasound Systems:
•
•
•
•
•
•
Result Pages : |